Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Formulary Announcement PAAB Exemption
-
In question #389, you stated that "The claim “Drug X 15mg [i.e. the strength] is now on [provincial] formulary” is exempt." Is it correct to assume that if a package shot is included in the APS (with no mention of indication in the APS), it is still exempt from review?
-
Good morning @tmcm
If the pack shot does not contain copy/visuals which would render the piece reviewable, it may be exempt. Some examples of copy on the pack shot which could render the piece reviewable would be showing a device, drug classification, stating “oral”, dosing, or administration instructions.
